DCT
3:18-cv-14305
Valeant Pharma North America LLC v. Mylan Pharma Inc
Log In
Overview
Analysis
General
Parties
Attorneys
Patents
Related Cases
Dockets
General
Filed
09/26/18
Cause of Action
Infringement
Sector
Biotech
Status
Closed (09/10/19)
Patent Owner
NPE
(L)
Source
PACER
Appeals
19-2402
Court
D. New Jersey
Judge
Period
PO Win Rate
Peter G. Sheridan
09/27/18 - 09/24/19
71%
Magistrate
Lois H. Goodman
Plaintiff
Party
Name
Ratings
Valeant Pharmaceuticals North America LLC
NPE
L4
A
Dow Pharmaceutical Sciences Inc
NPE
L4
A
Valeant Pharmaceuticals Ireland Ltd
NPE
L3
A
Kaken Pharmaceutical Co Ltd
L1
D
Show all (2 more)
Attorney
Name
Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP
L5
A
Justin J. Hasford
L5
A
Gibbons
Local
L3
B
William P. Deni, Jr.
L4
D
J. Brugh Lower
L3
D
Show all (-5 more)
Defendant
Party
Name
Ratings
Mylan Pharmaceuticals Inc
L3
B
Mylan Laboratories Ltd
L5
E
Mylan NV
L3
B
Show all (1 more)
Attorney
Name
Ratings
Wilson Sonsini Goodrich & Rosati
L5
A
Kristina M. Hanson
L5
A
Tung-On Kong
L5
A
Wendy L. Devine
L4
B
Anjali D. Deshmukh
L3
--
--
Saiber
Local
L3
E
Jeffrey S. Soos
L5
E
Arnold B. Calmann
L5
E
Katherine Ann Escanlar
L5
E
Show all (-1 more)